Across the entire study sample, CSF NfL remained significantly associated with WMH volume, even after adjusting for AD pathology markers (CSF Aβ42/Aβ40 ratio and p-tau181), supporting CSF NfL as a marker of white matter damage independent of AD pathology. This evidence concerns the gene NEFL and Alzheimer disease.